Pure Global

Cellbind Direct - Indonesia BPOM Medical Device Registration

Cellbind Direct is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20209124124. The device is manufactured by SANQUIN REAGENTS B.V. from Netherlands, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. MRK DIAGNOSTICS.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
Cellbind Direct
Analysis ID: AKL 20209124124

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

Netherlands

Authorized Representative

PT. MRK DIAGNOSTICS

AR Address

JL. Merpati Mas I Blok B1 NO.46 Perkantoran Tanjung Mas Raya Tanjung Barat

Registration Date

Jul 12, 2021

Expiry Date

Jan 31, 2025

Product Type

Products used in the manufacture of blood preparations and preparations of origin and blood

Automated blood grouping and antibody test system.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing